CAS RN: 22501-77-5
4-(5-METHYL-BENZOOXAZOL-2-YL)-PHENYLAMINE
Product Availability
Choose a grade to view its available package options.
4 package records0 with current stock1 grade group
| Batch No. | Package | Availability | Lead Time | Inquiry |
| Batchno.20260206 |
100mg |
Out of stock |
| Inquiry |
| Batchno.20251202 |
100mg / 250mg / 1g |
Out of stock |
5-7 business days | Inquiry |
| Batchno.20260306 |
1g |
Out of stock |
| Inquiry |
| Batchno.20250111 |
250mg |
Out of stock |
| Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.1g, 0.25g, 1g, 5g
- Available purity: >97%
- Inventory rows with stock: 4
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 22501-77-5
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.1g |
>97% |
1
In Stock
|
Shenzhen |
Inquiry |
| 0.25g |
>97% |
1
In Stock
|
Shenzhen |
Inquiry |
| 1g |
>97% |
1
In Stock
|
Beijing |
Inquiry |
| 5g |
>97% |
1
In Stock
|
Shanghai |
Inquiry |
22501-77-5 / 4-(5-methyl-1,3-benzoxazol-2-yl)aniline
Standard CAS: 22501-77-5
Multi CAS: No
Basic Information
CAS
22501-77-5
Multi CAS
No
Molecular Formula
C14H12N2O
Molecular Weight
224.260000
Exact Mass
224.094963
SMILES
CC1=CC2=C(C=C1)OC(=N2)C3=CC=C(C=C3)N
InChI
InChI=1S/C14H12N2O/c1-9-2-7-13-12(8-9)16-14(17-13)10-3-5-11(15)6-4-10/h2-8H,15H2,1H3
InChIKey
TZIKYKSWQZSLOO-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
17
Aromatic heavy atom count
15
Fraction Csp3
0.07
Rotatable bonds
1
H-bond acceptors
3
H-bond donors
1
Molar refractivity
68.59
TPSA
52.05
LogP / Solubility
WLOGP
3.39
MLOGP
2.98
XLogP3
3.1
Consensus LogP
3.16
Log S (ESOL)
-3.95
Class (ESOL)
Poorly soluble
Log S (Ali)
-3.84
Class (Ali)
Poorly soluble
Log S (SILICOS-IT)
-4.05
Class (SILICOS-IT)
Slightly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-1.68
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
1.5